Unpacking KDIGO’s Updated Clinical Practice Guidelines: Implications for IgAN Drug Development

Time: 8:30 am
day: Pre-Conference Focus Day

Details:

  • Examine the critical updates in KDIGO’s recommendations
  • Discuss how the guidelines’ shifts the clinical trial landscape, influencing the design of future trials and the search for novel therapeutic targets
  • Explore how KDIGO's updated treatment and diagnostic standards may affect regulatory approvals, reimbursement policies, and market access for IgAN therapies

Speakers: